Personal CFO Solutions LLC Raises Position in Intuitive Surgical, Inc. $ISRG

Personal CFO Solutions LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 128.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,321 shares of the medical equipment provider’s stock after purchasing an additional 1,306 shares during the period. Personal CFO Solutions LLC’s holdings in Intuitive Surgical were worth $1,315,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of ISRG. Riversedge Advisors LLC raised its position in Intuitive Surgical by 1.9% in the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after purchasing an additional 17 shares during the period. Prosperity Consulting Group LLC raised its position in Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares during the period. Fiduciary Financial Group LLC raised its position in Intuitive Surgical by 2.1% in the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after purchasing an additional 19 shares during the period. Rossmore Private Capital raised its position in Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after purchasing an additional 20 shares during the period. Finally, Activest Wealth Management raised its position in Intuitive Surgical by 21.7% in the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after purchasing an additional 20 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.1%

Shares of ISRG stock opened at $462.28 on Thursday. The firm has a fifty day moving average price of $483.27 and a 200 day moving average price of $514.06. The company has a market cap of $164.17 billion, a P/E ratio of 58.59, a PEG ratio of 3.49 and a beta of 1.68. Intuitive Surgical, Inc. has a 12 month low of $427.84 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s revenue was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.21 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In related news, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 2,362 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the transaction, the senior vice president owned 3,554 shares of the company’s stock, valued at approximately $1,772,308.72. The trade was a 39.93% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 32,943 shares of company stock valued at $17,279,568. Insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Royal Bank Of Canada boosted their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Piper Sandler restated an “overweight” rating and issued a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, Truist Financial boosted their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $607.00.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Stock advanced in the latest session, signaling short-term buying interest that reflects optimism about the company’s growth prospects. Intuitive Surgical, Inc. (ISRG) Advances But Underperforms Market: Key Facts
• Positive Sentiment: Coverage highlighting Intuitive’s AI push into surgical systems reinforces the long-term growth story (potential to improve outcomes, maintain da Vinci franchise leadership). This helps justify investor appetite despite near-term valuation questions. Intuitive Surgical’s AI Push Tests Valuation And Da Vinci Growth Story
• Positive Sentiment: Analyst/features pieces pointing to large new addressable markets (e.g., anti‑obesity procedures) and Intuitive’s strong balance-sheet position support a bullish multi‑year case. Intuitive Surgical Stock: The Dark Horse in the Massive Anti-Obesity Market
• Positive Sentiment: Coverage noting the company’s financial strength (low/no debt, strong margins) supports investor confidence in executing product and software roadmaps. This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market
• Neutral Sentiment: Erste Group made very small trims to FY2026 and FY2027 EPS estimates (FY26: $8.21 from $8.22; FY27: $9.52 from $9.54). The moves are minor but signal cautious modeling around near-term execution/visibility.
• Negative Sentiment: Goldman Sachs cut its price target from $714 to $609 but kept a Buy rating — a material reduction in upside that could pressure sentiment despite the maintained positive view. Goldman Sachs Adjusts Price Target on Intuitive Surgical to $609 from $714; Maintains Buy
• Negative Sentiment: Evercore published a pessimistic forecast for ISRG, adding near-term downside risk from an influential sell‑side voice. Evercore Issues Pessimistic Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.